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Massachusetts Life Sciences Center grant
to increase clinical trials at Baystate Health
Baystate Medical
Center has been awarded
$3,949,912 in grant funding from the Massachusetts Life Sciences Center
(MLSC) in an extremely
competitive program
designed to sustain the
Commonwealth’s competitive edge in advancing
human health.
“This support will
expand our capacity to
perform efficient and
compliant clinical trials by
building a Clinical Trials
Unit (CTU) at Baystate
Medical Center and
make novel treatments
available to our diverse
patient population. We
are grateful to MLSC, our
legislators, the Governor,
and the citizens of the
Commonwealth for this
investment in the future
of biomedical research in
western Massachusetts,”
says Dr. Peter Friedmann,
Chief Research Officer for
Baystate Health and Associate Dean for Research
at UMMS-Baystate. “For
Baystate Health and
UMMS-Baystate, it is an
opportunity to increase
access to innovative treatments for the patients and
communities we serve,
engage faculty and staff in
impactful clinical research,
expand collaborations with

L to R: State Sen. James Welch; Jane Albert, Senior Vice President of Marketing, Communications & External Relations, Baystate Health; John
Maybury, Chairman of the Board of Trustees, Baystate Health; State Rep. Carlos Gonzalez, State Sen. Eric Lesser; Travis McCready, President of
MLSC; State Rep. Brian Ashe; Dr. Mark Keroack, President and CEO of Baystate Health; Dr. Peter Friedmann, Chief Research Officer, Baystate
Health; State Rep. Joseph Wagner; Nancy Shendell-Falik, President of Baystate Medical Center; State Rep. Michael Finn; and Jean Ahn, Senior Vice
President and Chief Strategy Officer, Baystate Health.

academic and industry
partners, and improve the
productivity and efficiency
with which we conduct
clinical trials.”
Baystate is among
11 hospitals, colleges
and other institutions to
receive a total of $30.95
million in capital grant
funding to support the
state’s global leadership in the life sciences
sector. There were 45
applications. The funding, provided through
the MLSC’s Competitive Capital Program, is
designed to support
advances in human health,

accelerate innovation in
the areas of clinical and
translational research, and
expand the capacity of
life sciences development
and job growth across the
Commonwealth.
“The grant will expand
local capacity to perform
clinical trials of new innovations in digital health
and medical devices right
here in Springfield. We
know that Massachusetts
is a national leader in
health sciences, and
western Massachusetts
is no exception, with
new research happening at places like UMass

Amherst, and advances in
treatment happening regularly at Baystate Medical
Center, which makes this
new partnership so exciting. This will benefit the
entire Massachusetts life
sciences system and keep
western Massachusetts on
the map in this critical and
growing field,” says State
Senator Eric Lesser, who
worked to pass the Mass
Life Sciences Bill, which
funded this grant program.
Baystate has long partnered with the Center for
Clinical and Translational
Science (CCTS) at UMMSWorcester, Pioneer

Research Question? Call the Office of Research at our central number: 413-794-3391

Valley Life Sciences
Institute and the Institute
for Applied Life Sciences
at UMass Amherst in the
Center for Clinical and
Translational Investigation,
and the Clinical and Translational Science Institute at
Tufts to promote translational research in the
western part of the state.
Baystate’s Clinical Trials
Office (CTO) was launched
in 2018 to build upon
these research partnerships, as well as relations
with industry sponsors
to conduct innovative
translational research and
(Continued on page 2)
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TAVR research brings innovative, lifesaving heart procedure to Baystate

Members of the Baystate cardiology team: (L to R) Noel Harrington, Ashequl Islam, MD, and Grace Lavalley,
DNP, AGACNP-BC.

Aortic valve stenosis is a condition
where the heart’s aortic valve begins
to shrink, limiting blood flow from the
heart to the rest of the body. The most
common cause is the wearing down
of the valve due to age, like how your
car brakes wear down over time. This
process can lead to symptoms like shortness of breath and dizziness. You would
think that heart surgery is the automatic
solution, but for some patients, it is too
risky. A patient may be too old or frail to
be put under for surgery and recuperate
later on.
“Unfortunately, untreated aortic
valve disease is fatal. After the onset of
symptoms, the survival rate is as low as
50% at 2 years,” says Grace Lavalley,
DNP, AGACNP-BC, a cardiology nurse
practitioner. “The definitive treatment
for aortic valve stenosis has been valve
replacement surgery.” With regular aortic
valve replacement (AVR), the patient is
sedated and the chest is cut open. The
heart is stopped and an artificial unit is
used to pump the blood. The faulty valve
is surgically removed and replaced with
a new one. A patient may be in the ICU
for days after this surgery, and the chest
could take up to two months to heal
completely. This intensive surgery now
has a simpler solution with TAVR (Transcatheter Aortic Valve Replacement),
a minimally-invasive valve procedure.
A patient has to be referred by their
primary care provider or cardiologist to
receive TAVR.
“If AVR surgery is not an option, TAVR
is a fantastic alternative for those who
may be considered intermediate to high
risk for surgery,” adds Lavalley. TAVR
was first implemented in in-operable or
high-risk patients for surgery; indications
have since expanded to intermediate
risk. Baystate will see further expansion of indications to lower-risk patients
based on current low-risk trials done
in the United States. Interventional
cardiologist Ashequl Islam, MD was a

part of the cardiac team that brought
TAVR to Baystate and has studied its
effectiveness.
“We are excited to offer TAVR to the
very large patient population which we
serve,” he says. Results of nationwide
clinical trials for TAVR have shown better
or equivalent results compared to open
heart surgery. With TAVR, patients do
not undergo bypass, most have minimal
sedation, and their length of stay is
significantly reduced with no need for
intensive care. Patients are more alert
and awake and can be back on their
feet within hours.
To perform TAVR in majority of
patients, a small puncture is made in the
groin area and a catheter with the new
valve is inserted into the diseased valve,
diminishing the need for external pumps
to keep the heart and lungs working. The new valve is embedded and
anchored in the existing valve, giving it
new life. After the catheter is pulled out,
the entry site is stitched up.
“TAVR is one of those revolutionary
procedures that has really changed the
world of cardiac care,” adds Dr. Islam.
“A lot of patients couldn’t get treatment before this. Baystate is the only
advanced heart and vascular hospital in
western Massachusetts and this allows
us to deliver state-of-the art, high quality
care. Cardiac patients would have to go
out of the Baystate network if not for this
type of procedure.” The cardiology team
has expanded from TAVR to other valve
procedures and treatments, including
catheter-based mitral valve repair. They
are also involved in clinical trials to
investigate non-surgical treatment methods for other heart valve conditions.
“We are always looking at new and
innovative ways to deliver the best heart
care to our patients,” concludes Dr.
Islam.
For more information on Baystate’s
Heart and Vascular program, visit baystatehealth.org/services/heart-vascular.

(Continued from page 1)

high-impact clinical trials.
Among the many project objectives – which
are also funded in part
by a $550,000 commitment from BH in 2019 to
develop the Clinical Trials
Unit – are to:
• Create a physical outpatient CTU and outpatient
research pharmacy at
3300 Main St. in Springfield and a satellite unit at
Baystate Franklin Medical
Center in Greenfield.
• Refurbish space in
BMC’s 3601 Main Street
building in Springfield
to provide cubicle and
office space for clinical
research personnel and
interns.
• Work with local community colleges to develop

internships and programs
to ensure a trained workforce in clinical research,
including the creation of
a Certificate in Clinical
Research.
“We will work with
the life sciences degree
programs at STCC, HCC,
and Greenfield Community College to facilitate
training and workforce
development from which
we can recruit and train
qualified research staff,”
adds Dr. Friedmann. “We
believe we can achieve a
five-fold increase in active
clinical trials throughout
Baystate Health by 2023,
speeding the human testing of these innovative
medications, devices, and
digital health products.”

Research & Education Celebration
held on May 15, 2019

Timothy Mader, MD, receives the
Excellence in Research Mentoring
Award from Dr. Friedmann and
Jenn Pacheco, MPH, CIM, CIP.

Dr. Tara Lagu speaks during one
of the day’s panel discussions.

Laura Gebhardt receives the
Award for Outstanding Clinical
Research Support.

Attendees stop for a photo.

Mihaela Stefan, MD, PhD, is the
recipient of the Research Translation Award.

An attendee reads the last issue
of The Innovator.

(Above and below) Attendees
gather around the posters at the
Poster Session.

Lili Peacock-Chambers, MD,
MSc, receives the Early Career
Investigator Award from Dr. Peter
Lindenauer.
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Baystate’s new ovarian tissue registry: a team effort
THE PROCESS OF THE OVARIAN TISSUE REGISTRY
#1 Dr. Tashanna Myers: Asks a patient for consent to
participate in ovarian tissue registry.
#2 Lynn Eaton, MT (ASCP), CCRP: Alerted that the tissue
will be collected, enrolls the patient into the database and
gets all remaining parts in place.
#3 Tissue is collected at time of surgery.
#4 Dr. Christopher Otis: Oversees proper procurement of
collected tissue.
#5 Dr. Sallie Schneider: Receives the tissue and
coordinates the processing for the tissue bank. Ensures
tissue is available in multiple forms for research purposes.
#6 Dr. Esma Ersoy: One of the many residents who will be
researching the ovarian tissue.

The ovarian tissue registry team at Baystate Health: (L to R) Christopher Otis, MD, Tashanna Myers, MD, Sallie
Schneider, PhD, Lynn Eaton, MT (ASCP), CCRP, and Esma Ersoy, MD.

The ovarian tissue
registry at Baystate began
at the end of 2018 as a
collaboration among Drs.
Sallie Schneider (Director of the Biospecimen
Resource and Molecular
Analysis Facility; Pioneer
Valley Life Sciences
Institute), Tashanna Myers
(Gynecologic Oncology),
and Christopher Otis (Anatomic Pathology). Their
goal is to collect samples
of ovarian tissue from
consenting patients as
part of a research registry.
The ovarian tissue registry
is modeled after the
successful Rays of Hope
Breast Tissue Registry at
Baystate.
“In breast cancer, it is
often difficult to get tumor
tissue because the tumors
are usually very small
when first detected and
the margins are important
for diagnosis,” explains
Dr. Schneider. “Ovarian

cancer is usually found too
late, and at this point the
tumors are very large.”
Patients who are
already undergoing
surgery to remove part
of or the entire ovary are
approached by surgeons
in the hospital to see if
they’d like to contribute to
the ovarian tissue registry.
To participate, the patient
must be an adult, must
be able to give their own
consent, and must have
a scheduled surgery
where an ovary is being
removed. Surgeons will
send tumor tissue (such
as an ovarian mass) to the
pathologist who examines the specimen and
chooses tumor tissue to
submit to the tissue bank.
Lynn Eaton, MT (ASCP),
CCRP, Senior Clinical
Research Coordinator, is
the individual who ensures
the entire procedure runs
smoothly from start to
finish.

“Although we come
from different departments, we all work
together as a team,” Eaton
says. “It’s a very collaborative process involving the
surgeon’s staff assistant,
the pre-admission chart
room, the surgeon and
surgery personnel, PVLSI
staff, pathology administrative staff, and the pathologists.” Dr. Christopher Otis,
who oversees the procurement of the collected
tissue, makes sure it is
handled appropriately as it
is put into the registry. Dr.
Esma Ersoy, a pathology
resident, is also involved
in this process since she
has a particular interest in
a specific protein (HER2)
found within ovarian
tumors.
“Once the tumor cells
are collected, the next
step is to understand their
characteristics.” says Dr.
Ersoy. “We ask things like
‘What stage is this tumor

in? Are the cells resistant
to chemotherapy? What
kind of targetable proteins
(e.g. HER2) are involved in
the tumorigenesis? Are the
cells resistant to chemotherapy?’” Since there are
so many different types
of cancers and variations
of cancer cells, extensive
research is necessary to
work toward finding effective treatments.
“In the era of precision medicine, we know
that cancer cells can be
diverse,” explains Dr.
Myers. “Standard chemotherapy will not be
sufficient to finding a cure
for this disease. Studying
individual tissue samples
will be key to answering
questions about ovarian
cancer.” As of May 2019,
over 20 ovarian tissue
samples have been collected.
“As the registry grows,
we will see more peaks
of abnormalities and
averages,” adds Dr. Otis.
“We will learn more about
the disease and offer/
develop new treatments
to be delivered to the

Baystate Health named a top MA employer!
Baystate Health was ranked the 14th (of 74) best Massachusetts
employer through a study conducted by Forbes partnering with market
research company Statista. The goal was to identify organizations
liked best by employees in Forbe’s first-ever ranking of America’s best
employers by state. The list was compiled through an anonymous
survey of 80,000 Americans nationally working for businesses with at
least 500 employees. On a scale of zero to 10, participants rated how
likely they’d be to recommend their employer to others. The final list
ranks 1,430 employers which received the most recommendations in
each of the 50 states and the District of Columbia.

bedside. This is important
translational research.”
Many patients who are
approached by Dr. Myers
and her team are eager
and excited to participate
in the ovarian tissue bank.
“Patients have been
selfless and want to help
others who might be
experiencing the same
issues,” explains Dr. Myers.
“The tissue we collect is
impactful beyond that one
single patient. We want
to change the course of
ovarian cancer treatment
and figure out the causes.”
The hope is that this
research will answer questions about ovarian cancer
in the future and why
ovarian cells can become
cancerous.
“Through this research,
we are creating something
meaningful for years to
come,” concludes Dr.
Ersoy. “It’s being part of
a bigger picture. With
Baystate becoming more
of an academic institution, research like this
is important for us to
grow and strengthen our
knowledge.”

4 | The Innovator

Meet the Researcher

Dr. Schoenfeld and her family.

Name: Elizabeth
Schoenfeld, MD,
MS
Title/Academic
Rank: Assistant
Professor
Department:
Emergency
Medicine, Institute
for Healthcare
Delivery and
Population
Science (IHDPS)

Number of years at Baystate: 8.5
What research training do you have? Masters in Clinical and
Translational Research from Tufts, Mentorship from the IHDPS
What got you interested in research overall? I wanted
to teach the residents evidence-based medicine, but
many of the things that I thought were "right" in terms of
care of patients, had little evidence (and conversely, many
of the things we do regularly, also have little evidence).
Research is a way of getting at the "truth" and what is right
– and demonstrating "right" with science, rather than with
persuasion.
What is your area of research? I study the use of Shared
Decision-Making in the Emergency Department – specifically
whether we can use Shared Decision-Making to decrease
advanced imaging and improve patients' experiences.
How do you see your research improving care for patients?
In my newest study, we have the potential to decrease young
patients' exposure to ionizing radiation, which will decrease
future cancer incidence. This is obviously important for
peoples' health in the long term. But using Shared DecisionMaking has the potential to improve short-term health too.
By creating an environment where patients see themselves
as part of the team and full players, we have the potential to
improve adherence and trust within the system, which can
improve health and well-being in the short term, too.
What have been some of your favorite research projects
to date that you have organized/participated in? In my
qualitative projects, I get to interview doctors and patients –
this is always a lot of fun.
Do you have any awards? Baystate gave me the New
Investigator Award in 2017. And this past winter I won for my
age division in a slalom race in Vermont – there were only
two of us, and we both fell, but I think I hiked back through the
gates faster...
What do you like most about your job? I am very lucky to
get to spend so much of my time on research. I love working
clinically, but I get to spend my other days trying to find ways
to improve the care we provide – and then designing studies
to test whether my ideas work. It takes a lot of time, but I get
to work with great people. Plus, sometimes the evidence
suggests I'm right, so that's nice. (Nothing is ever "proven,"
though – so I never really "prove" that I'm right.)
What do you do to unwind outside of work? When I'm not
playing/coaching soccer with my kids, I'm downhill mountain
biking (summer/fall) or skiing. If you'd like to try downhill
mountain biking with me, just let me know! We can meet at
Berkshire East and talk study design on the lifts.
The
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We are interested in ensuring that Baystate employees and patients (and their
families) are aware of the important research that goes on at Baystate and how it
contributes to better patient care. The Innovator welcomes feedback and story
ideas. Contact Allison Litera at allison.litera@baystatehealth.org to submit yours.

Research Training for Fellows and Junior Faculty
Baystate offers several training and career development opportunities for residents,
fellows, and junior investigators.

Training the next generation of
healthcare researchers is a priority for
UMMS-Baystate, and a major focus for
our Institute for Healthcare Delivery and
Population Science (IHDPS). Thanks
to our affiliations with the Clinical and
Translational Science Awards at UMMS
and Tufts, our trainees and faculty can
develop skills to expand the critical
mass of expert scientists in clinical and
translational research through innovative education, training, and mentoring
programs.
For junior faculty, career development
awards go by a “K” designation; both
Tufts and UMass sponsor institutional
KL-2s, while UMass sponsors the K-12.
These highly competitive awards will
fund up to 75% effort to train in research
and perform a mentored research project over 2-3 years. In addition to these
mentored career development grants,
fellowships and forums for junior faculty
are available as well.
A K-12 from the University of Massachusetts Medical School and its Massachusetts Consortium for Cardiopulmonary Implementation Science currently
supports IHDPS fellow Lauren Westafer,
DO, MPH, MS, Assistant Professor in the
Department of Emergency Medicine,
to gain expertise in implementation
science, as well as to develop and test
strategies for moving evidence into
routine practice.

Lauren Westafer, DO, MPH, MS

“My grant enables me to study
provider decision-making in the
diagnostic evaluation of pulmonary
embolism. What we're seeing is that
providers are overtesting patients for
this disease process, despite guidelines
and evidence-based algorithms. I'm
working to figure out – ‘how do we get
providers to use these tools for more
rational testing?’ The grant is giving me
an invaluable opportunity to work on
this project, take classes, conduct other
projects, and receive amazing mentorship from top researchers to build skills
as a clinician-investigator.”
The KL-2, available both from Tufts
Clinical and Translational Science
Institute (CTSI) and the UMMS Center
for Clinical and Translational Sciences, is

another mentored career development
award with a broad focus on translational science. Lili Peacock-Chambers,
MD, MSc, Assistant Professor in the
Department of Pediatrics and Fellow
in the IHDPS, has a KL-2 through Tufts
focused on developing tools to help
mothers with opioid addiction and to
take better care of their children.

Lili Peacock-Chambers, MD, MSc

“My KL-2 is focused on adapting
and integrating an evidence-based
parenting intervention for mothers in
recovery from opioid use disorders into
Early Intervention child development
services. We have conducted nearly 30
mothers in recovery and 25 community
stakeholders to inform the adaptation of
our intervention. In addition we formed
an advisory panel to guide our work.
We are in the process of deploying our
newly adapted training and intervention
the summer of 2019. I have personally
advanced my training in qualitative
and community-engaged research and
received excellent support in both grant
and manuscript writing.”
Training grants for post-docs
(residents and fellows) have a “T”
designation. These are 2-year training
programs that provide salary support
with expectation that the trainee spends
75% of their time engaged in research.
There are no Baystate post-docs in the
T program at this time. Through both
the T and K grants, trainees have the
opportunity to pursue research under
a team of mentors and to pursue and
complete a Master’s degree in clinical/
translational research. These training
grants provide outstanding opportunities for residents and fellows who wish
to take time to develop research skills.
Both UMMS CCTS and Tufts CTSI
offer a wide array of courses, workshops, and seminars in topics such
as clinical and translational research,
career development, grant writing,
quality improvement, and regulatory
affairs. They also have mentoring support grants, fellowships, and a forum
for junior faculty. To learn more, visit
umassmed.edu/ccts/education or
tuftsctsi.org.

